NHS England Drugs of Low Clinical Priority
NHS England have identified 18 medicines/items of low clinical value. These are for ineffective, over-priced or low value treatments and are a focus in our Medicines Optimisation LES (MOLES).
Below are the resources to support practices when reviewing them which includes prescribing policy statements, service restriction policies and switching guidance for each item.
pdf Complementary and Alternative Therapies Service Restriction Policy Oct 2016 (126 KB)
pdf Dosulepin August 2017 (325 KB)
Erectile dysfunction - Tadalafil January 2019
Fentanyl Immediate release products Oct 20
pdf Gluten free food January 2016 (274 KB)
Lidocaine MSEMOC policy statement May 21
document Lidocaine weaning patient letter (19 KB)
Liothyronine MSEMOC position statement Nov 20
pdf Lutein and antioxidants August 2017 (529 KB)
Omega 3 fatty acids February 2015
Oxycodone & Naloxone combination product (Targinact) MSEMOC position statement Oct 20
Perindopril Arginine August 2017
pdf (82 KB) Tramadol & paracetamol combination product (Tramacet®) MSEMOC position statement Oct 20
pdf Travel Vaccines April 2017 (358 KB)
pdf Patient FAQ NHS England low clinical priority Jan 2018 Final (324 KB)